(Q36909277)

17 August 2017

1 reference

title

Giardiasis: a pharmacotherapy review (English)

1 reference

17 August 2017

0 references

Angel A Escobedo

1

1 reference

17 August 2017

Sergio Cimerman

series ordinal

2

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 August 2007

1 reference

Expert Opinion on Pharmacotherapy

17 August 2017

published in

1 reference

17 August 2017

volume

8

1 reference

17 August 2017

issue

12

1 reference

17 August 2017

page(s)

1885-1902

1 reference

Current trends in research into the waterborne parasite Giardia

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Microbial agents associated with waterborne diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Biliary tract dysfunction in giardiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Giardiasis: a histologic analysis of 567 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Effect of Giardia infection on growth and psychomotor development of children aged 0-5 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Giardia lamblia carriage in Israeli Bedouin infants: risk factors and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Aphthous ulceration as a presentation of Giardia lamblia infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Giardiasis-associated arthralgia in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Whipple disease associated with giardiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Concurrent Whipple's disease and Giardia lamblia infection in a patient presenting with weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

My favorite cell: Giardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Albendazole as a treatment for infections with Giardia duodenalis in children in Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from Northern Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Comparative clinical trial of mebendazole and metronidazole in giardiasis of children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Giardiasis treatment in Turkish children with a single dose of ornidazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Albendazole as an alternative therapeutic agent for childhood giardiasis in Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Mutagenicity of metronidazole: Activation by mammalian liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Cytogenetic evaluation of two nitroimidazole derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Late incidence of cancer after metronidazole use: a matched metronidazole user/nonuser study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Comparison of chloroquine, albendazole and tinidazole in the treatment of children with giardiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Evaluation of genetic damage induced by a nitroimidazole derivative in human lymphocytes: Tinidazole (TNZ).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Ornidazole-induced liver damage: report of three cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

A new screening assay for antigiardial compounds: effects of various drugs on the adherence of Giardia duodenalis to Caco2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

A randomized trial comparing mebendazole and secnidazole for the treatment of giardiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Secnidazole. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic use in the management of protozoal infections and bacterial vaginosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Chemotherapeutic approaches to protozoa: Giardia, Trichomonas and Entamoeba--current level of knowledge and outlook

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Randomized clinical study of five days apostrophe therapy with mebendazole compared to quinacrine in the treatment of symptomatic giardiasis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

21 January 2018

Treatment of giardiasis.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Quinacrine-induced psychiatric disturbances in a child with common variable immunodeficiency and chronic giardiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Furazolidone-induced mood disorder during the treatment of refractory giardiasis in a patient with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Comparisons of ribosomal RNA sequences from amitochondrial protozoa: implications for processing, mRNA binding and paromomycin susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Antiprotozoal activities of benzimidazoles and correlations with beta-tubulin sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Characterisation of benzimidazole binding with recombinant tubulin from Giardia duodenalis, Encephalitozoon intestinalis, and Cryptosporidium parvum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Failure of mebendazole treatment in Giardia lamblia infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Population-based case-control study of mebendazole in pregnant women for birth outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Pregnancy outcome after gestational exposure to mebendazole: a prospective controlled cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Lack of risk of adverse birth outcomes after deworming in pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Albendazole is highly effective against cutaneous larva migrans but not against Giardia infection: results of an open pilot trial in travellers returning from the tropics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Intestinal elimination of albendazole sulfoxide: pharmacokinetic effects of inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Ginseng increases intestinal elimination of albendazole sulfoxide in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Assessing the risk of benzimidazole therapy during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Inadvertent exposure of pregnant women to ivermectin and albendazole during mass drug administration for lymphatic filariasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

In vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis and Trichomonas vaginalis trophozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Nitazoxanide pharmacokinetics and tolerability in man using single ascending oral doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or E. dispar: a randomized, double-blind, placebo-controlled study of nitazoxanide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Successful treatment of metronidazole- and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Antigiardial activity of the bile salt-like antibiotic sodium fusidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Cytotoxicity Induced by Bismuth Subcitrate in Giardia lamblia Trophozoites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

The cytotoxic effects of ciprofloxacin in Giardia lamblia trophozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Synthesis and in vitro antiprotozoal activity of 5-nitrothiophene-2-carboxaldehyde thiosemicarbazone derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Synthesis and antiparasitic activity of 1H-benzimidazole derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Synthesis, antiprotozoal and anticancer activity of substituted 2-trifluoromethyl- and 2-pentafluoroethylbenzimidazoles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Synthesis, and antiprotozoal and antibacterial activities of S-substituted 4,6-dibromo- and 4,6-dichloro-2-mercaptobenzimidazoles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Menadione kills trophozoites and cysts of Giardia intestinalis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Giardia lamblia: evaluation of the in vitro effects of nocodazole and colchicine on trophozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

The effects of saturated fatty acids on Giardia duodenalis trophozoites in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Evaluation of silymarin in the treatment on asymptomatic Giardia infections in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

In vitro effects of thiazolides on Giardia lamblia WB clone C6 cultured axenically and in coculture with Caco2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Embryolethality induced by metronidazole (MTZ) in Rattus norvegicus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Diarrhoeal disease: current concepts and future challenges. Pathogenesis of giardiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Proton-pump inhibition and gastric giardiasis: a causal or casual association?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Prevalence of intestinal parasites in Cuban acquired immunodeficiency syndrome (AIDS) patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Epidemiology of infections with intestinal parasites and human immunodeficiency virus (HIV) among sugar-estate residents in Ethiopia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Treatment of patients with refractory giardiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Biliary giardiasis in a patient with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Coinfection with Giardia lamblia and Clostridium difficile after use of ranitidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Sensitivity in vitro of Giardia intestinalis to dyadic combinations of azithromycin, doxycycline, mefloquine, tinidazole and furazolidone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

In vitro activity of two phenyl-carbamate derivatives, singly and in combination with albendazole against albendazole-resistant Giardia intestinalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

Giardiasis in HIV: a possible role in patients with severe immune deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1885

10.1517/14656566.8.12.1885

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference